Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jan 2013. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 71871801000001118 | Komboglyze | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 71871901000001112 | Komboglyze (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Komboglyze | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Komboglyze 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Komboglyze | Inferred relationship | Existential restriction modifier | |
| Komboglyze 2.5mg/1000mg tablets (DE Pharmaceuticals) | Is a | True | Komboglyze | Inferred relationship | Existential restriction modifier | |
| Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) | Is a | True | Komboglyze | Inferred relationship | Existential restriction modifier | |
| Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) | Is a | True | Komboglyze | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR